This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

On Stone-Linx deal in Brazil, no remedy discussions emerge ahead of CADE Tribunal session

By Flavia Fortes ( May 10, 2021, 18:43 GMT | Insight) -- The Brazil review of Stone’s proposed acquisition of software maker Linx hasn’t resulted in any remedy talks, MLex has learned. The deal, approved unconditionally by Brazilian antitrust investigators, is scheduled for a vote by the agency’s Tribunal Wednesday, but the ruling could be postponed for a later session.The Brazil review of Stone’s proposed acquisition of software maker Linx hasn’t resulted in any remedy talks, MLex has learned....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login